Pharmaniaga Berhad (KLSE:PHARMA)

Malaysia · Delayed Price · Currency is MYR

0.8950

-0.0250 (-2.72%)

At close: Oct 9, 2026

Market Cap	1.17B -36.1%
Revenue (ttm)	4.17B +5.8%
Net Income	58.94M -57.0%
EPS	0.05 -90.0%
Shares Out	1.31B
PE Ratio	18.80
Forward PE	4.83
Dividend	0.02 (1.93%)
Ex-Dividend Date	Sep 14, 2026

Volume	3,082,000
Open	0.9150
Previous Close	0.9200
Day's Range	0.8950 - 0.9300
52-Week Range	0.8950 - 1.7000
Beta	0.67
Analysts	Buy
Price Target	1.53 (+70.95%)
Est. Earnings	Nov 27, 2026

About Pharmaniaga Berhad

Pharmaniaga Berhad, an investment holding company, operates as an integrated healthcare service provider in Malaysia, Indonesia, and internationally. The company operates through Logistics and Distribution, Manufacturing, and Indonesia segments. It is involved in manufacturing, distribution, and marketing of pharmaceutical and medical products, such as generic drugs and over-the-counter medicines; supply and installation of medical and hospital equipment; and research and development of pharmaceutical products. The company also produces and dis... [Read more]

Industry Drug Stores and Proprietary Stores

Founded 1994

Employees 3,502

Stock Exchange Bursa Malaysia

Ticker Symbol PHARMA

Full Company Profile

Financial Performance

In 2025, Pharmaniaga Berhad's revenue was 3.93 billion, an increase of 4.48% compared to the previous year's 3.76 billion. Earnings were 48.51 million, a decrease of -63.20%.

Financial Statements

Analyst Summary

According to 3 analysts, the average rating for PHARMA stock is "Buy." The 12-month stock price target is RM 1.53, which is an increase of 70.95% from the latest price.

Price Target

RM 1.53

(70.95% upside)

Analyst Consensus: Buy

Stock Forecasts